Type III CRISPR-Cas: beyond the Cas10 effector complex

Trends Biochem Sci. 2023 Nov 8:S0968-0004(23)00261-X. doi: 10.1016/j.tibs.2023.10.006. Online ahead of print.ABSTRACTType III CRISPR-Cas loci encode some of the most abundant, yet complex, immune systems of prokaryotes. They are composed of a Cas10 complex that uses an RNA guide to recognize transcripts from bacteriophage and plasmid invaders. Target recognition triggers three activities within this complex: ssDNA degradation, synthesis of cyclic oligoadenylates (cOA) that act as second messengers to activate CARF-domain effectors, and cleavage of target RNA. This review covers recent research in type III CRISPR-Cas systems that looked beyond the activity of the canonical Cas10 complexes towards: (i) ancillary nucleases and understanding how they provide defense by sensing cOA molecules; (ii) ring nucleases and their role in regulating cOA production; and (iii) CRISPR-associated proteases, including the function of the Craspase complex in a transcriptional response to phage infection.PMID:37949766 | DOI:10.1016/j.tibs.2023.10.006

Source: Trends in Biochemical Sciences - November 10, 2023 Category: Biochemistry Authors: Gianna Stella Luciano Marraffini Source Type: research